Morgan Stanley plans contingent income autocallables linked to Celgene

By Susanna Moon

Chicago, Jan. 7 – Morgan Stanley plans to price contingent income autocallable securities due Dec. 31, 2018 linked to Celgene Corp. shares, according to an FWP filed with the Securities and Exchange Commission.

The notes will pay a contingent quarterly payment at an annual rate of 9% if Celgene stock closes at or above the coupon barrier level, 75% of the initial price, on a determination date for that quarter.

The notes will be redeemed at par of $1,000 plus the contingent payment if Celgene stock closes at or above its initial price on any of the first 11 determination dates.

If the stock finishes at or above the 75% trigger level, the payout at maturity will be par plus the contingent quarterly payment.

Otherwise, investors will be fully exposed to any losses.

Morgan Stanley & Co. LLC is the agent.

The notes will price on Jan. 8 and settle on Jan. 13.

The Cusip number is 61765U647.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.